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Introduction
Cell polarity creates unique functional domains within cells, ex-
emplifi  ed by axons and dendrites of neurons and the apical and 
basolateral surfaces of epithelial cells (Drubin and Nelson, 
1996; Caplan, 1997; Horton and Ehlers, 2003). Cells generate 
polarity, in part, through directed transport of secretory vesicles 
and mRNAs by cytoskeleton-based motor proteins (St  Johnston, 
1995; Caplan, 1997; Pruyne and Bretscher, 2000; Lopez de 
  Heredia and Jansen, 2004; Czaplinski and Singer, 2006). Motor 
proteins involved in the transport of vesicles and mRNAs have 
been identifi  ed, and much is known about how these motor pro-
teins move along actin fi  laments and microtubules in vitro (Vale 
and Milligan, 2000). Less clear is how in vitro motility translates 
into long distance transport of cargo in vivo. In particular, the 
obvious physical differences between cargo, such as membrane-
bound vesicles and RNAs, would seem to necessitate different 
mechanisms to generate sustained transport in vivo.
To address this question, we analyzed two class V myosins 
in the budding yeast Saccharomyces cerevisiae: Myo2p and 
Myo4p. Together, the two myosins transport most of the cellular 
material into the bud (Bretscher, 2003). Myo2p is required for 
cell viability and is essential for the transport of secretory vesicles 
into the bud to facilitate growth (Johnston et al., 1991). Myo2p 
also transports other membrane-bound cargo, including vacu-
oles, late Golgi, peroxisomes, and mitochondria (Beach et al., 
2000; Catlett et al., 2000; Hoepfner et al., 2001; Rossanese 
et al., 2001; Itoh et al., 2002). In contrast, Myo4p is nonessen-
tial, but its primary biological function is to transport ASH1 
mRNA to the bud tip, generating cell fate differences between 
mother and daughter cells (Haarer et al., 1994; Long et al., 
1997; Takizawa et al., 1997). Myo4p has also been implicated 
in the movement of cortical ER into the bud (Estrada et al., 
2003). Myo2p and Myo4p are closely related and are descended 
from a common ancestral gene, but they cannot functionally 
substitute for each other, indicating that they have evolved to 
transport different types of cargo.
To move cargo over appreciable distances, motors must 
bind tightly to membranes and nucleic acids. Myo2p binds 
membrane-bound vesicles and organelles through separate do-
mains in its globular C-tail. For example, amino acids 1389–
1491 facilitate association with secretory vesicles, whereas amino 
acids 1131–1345 mediate association with vacuoles (Catlett et al., 
2000; Pashkova et al., 2005). These sequences do not appear to 
bind directly to membranes; rather, protein intermediaries tran-
siently link Myo2p to different membrane-bound cargo. For 
  example, Vac8p and Vac17p mediate the binding of Myo2p to 
vacuoles, whereas Sec4p likely facilitates the binding of Myo2p to 
vesicles (Wagner et al., 2002; Tang et al., 2003). The interaction 
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he yeast Saccharomyces cerevisiae uses two class V 
myosins to transport cellular material into the bud: 
Myo2p moves secretory vesicles and organelles, 
whereas Myo4p transports mRNA. To understand how 
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motor density. Third, single molecules of Myo2p are 
weakly processive, whereas individual Myo4p motors are 
nonprocessive. Finally, Myo4p self-assembles into multi-
motor complexes capable of processive motility. We show 
that the unique motility of Myo4p is not due to its motor 
domain and that the motor domain of Myo2p can trans-
port ASH1 mRNA in vivo. Our results suggest that the 
oligomeric state of Myo4p is important for its motility and 
ability to transport mRNA.
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between Myo2p and vacuoles is dissolved by the proteolysis of 
Vac17p (Tang et al., 2003). In contrast, Myo4p binds ASH1 
mRNA through She3p (Takizawa and Vale, 2000). Myo4p di-
rectly binds the N terminus of She3p, and the C terminus of 
She3p associates with ASH1 mRNA (Bohl et al., 2000). Another 
RNA-binding protein, She2p, facilitates a specifi  c interaction 
between She3p and sequences in ASH1 mRNA called zipcodes 
that are suffi  cient to localize an RNA (Bohl et al., 2000; Long 
et al., 2000).
In S. cerevisiae, vesicles and mRNA move rapidly and 
continuously into the bud. Myo2p moves secretory vesicles at 
rates around 3 μm/s, and Myo4p transports RNA at 0.25–0.4 μm/s 
(Bertrand et al., 1998; Schott et al., 2002). How Myo2p and 
Myo4p facilitate long distance transport in vivo is unclear, as 
an initial analysis of Myo2p and Myo4p motility indicated that 
both are nonprocessive (Reck-Peterson et al., 2001). Processive 
motors have a high probability of remaining associated with a 
fi  lament through many enzymatic cycles, allowing them to move 
considerable distances before falling off a fi  lament. In contrast, 
nonprocessive motors have a low probability of maintaining an 
association with a fi  lament during their enzymatic cycles, pre-
venting individual nonprocessive motors from moving along a 
fi  lament. Groups of nonprocessive motors bound to the same cargo 
might generate sustained movement by providing multiple attach-
ments to a fi  lament, thereby increasing the probability that the 
cargo remains associated with a fi  lament. Vesicles and organelles 
contain ample surface area to bind multiple motors, and recent 
work has shown that vesicles and some organelles use multiple 
motors to generate bidirectional transport, as well as increase the 
distance of sustained movement (Miller and Sheetz, 2000; Levi 
et al., 2006; Gross et al., 2007). Whether a similar mechanism 
works for mRNA transport is unclear. ASH1 mRNA contains four 
zipcodes, but a single zipcode is suffi  cient to generate continuous 
transport of an RNA to the bud tip (Chartrand et al., 1999). More-
over, active zipcodes can be as small as 25 nucleotides, clearly 
limiting the number of Myo4p motors that could bind (Jambhekar 
et al., 2005; Olivier et al., 2005). The spatial restriction of zipcode 
suggests that Myo4p likely utilizes a different mechanism than 
Myo2p to generate continuous movement of RNA.
Here, we have compared the structure and motility of 
Myo2p and Myo4p and discovered two substantial differences. 
First, Myo4p is a monomeric motor, whereas Myo2p, like all 
other class V myosins, is a dimer. Second, the in vitro motility 
of Myo2p and Myo4p were very different. In an actin fi  lament 
gliding assay, as Myo2p density decreased, fi  lament velocity 
decreased, indicative of a nonprocessive motor. In contrast, as 
Myo4p density decreased, fi  lament velocity increased, suggest-
ing that Myo4p is more effi  cient in smaller groups. Single-
molecule analysis demonstrated that Myo2p motors are weakly 
processive, and although individual Myo4p motors are nonproc-
essive, ensembles of Myo4p can move processively. To deter-
mine whether the motor domain of Myo4p is responsible for the 
unique motility of Myo4p, we constructed chimeras of Myo2p 
and Myo4p. We found that a Myo2p-motor/Myo4p-tail chimera 
(Myo2/4p) is a monomer with motility similar to Myo4p, whereas 
a Myo4p-motor/Myo2p-tail chimera (Myo4/2p) is a dimer 
with motility similar to Myo2p. Moreover, Myo2/4p restored 
localization of ASH1 mRNA to the bud tip in myo4∆ cells, and 
Myo4/2p restored vesicle transport in a myo2 mutant. Our results 
suggest that the monomeric structure of Myo4p is important for 
regulating its motility and transporting mRNAs in vivo.
Results
Myo4p is a monomeric class V myosin
Class V myosin heavy chains are predicted to dimerize through 
coiled-coil interactions in their proximal tail domain (Espreafi  co 
et al., 1992). For vertebrate myosin Va, dimerization allows 
the two motor domains to coordinate their enzymatic cycles to 
produce fast and processive movement along actin fi  laments 
(Purcell et al., 2002, 2005; Baker et al., 2004; Veigel et al., 2005). 
The pair-coil algorithm predicts a robust region of coiled-coil in 
the myosin Va C-tail, and a similar stretch of coiled-coil is found 
in the C-tail of Myo2p (Fig. 1 A). In contrast, Myo4p contains 
a limited stretch of amino acids (aa 990–1027) predicted to form 
a coiled-coil, and such a short coiled-coil domain may be insuffi  -
cient to facilitate dimerization of Myo4p heavy chains (Fig. 1 A). 
Because of the importance of dimerization in motor function, we 
investigated whether Myo4p exists as a monomer or dimer.
We fi  rst tested for Myo4p dimers using a coimmuno-
precipitation assay. Two versions of Myo4p with different 
C-terminal tags were expressed in the same cell. MYO4-GFP 
was integrated and under the control of its native promoter, 
whereas MYO4-HA was expressed from a low copy CEN/ARS 
plasmid. Anti-GFP antibodies were used to immunoprecipitate 
Myo4p-GFP, and the amount of Myo4p-HA in the immuno-
precipitates was determined by Western blot. We did not detect 
Myo4p-HA in immunoprecipitates of Myo4p-GFP, suggesting 
that the two heavy chains do not interact. (Fig. 1 B). As a control, 
we probed the Myo4p-GFP immunoprecipitates for She3p-HA, 
which binds directly to Myo4p. She3p-HA was readily detected 
in Myo4p-GFP immunoprecipitates (Fig. 1 B), indicating that 
most Myo4p heavy chains associate with She3p, but not with 
another Myo4p heavy chain.
To demonstrate that the coimmunoprecipitation assay can 
detect myosin dimers, we analyzed Myo2p. MYO2 or MYO4 were 
tagged at their C termini with a 1/2TAP module (TEV cleavage 
site and IgG-binding domain) and coexpressed with MYO2-HA 
or MYO4-HA, respectively. Myo2p-1/2TAP or MYO4p-1/2TAP 
were adsorbed from cell extracts onto IgG resin, and the amount 
of Myo2p-HA or Myo4p-HA in the immunoprecipitates was 
determined by Western blot. Myo2p-HA was clearly present in 
the immunoprecipitates of Myo2p-1/2TAP, but we failed to de-
tect Myo4p-HA in the immunoprecipitates of Myo4p-1/2TAP 
(Fig. 1 C). We achieved similar results using other combinations 
of tagged Myo2p and Myo4p (unpublished data). The results 
demonstrated that the coimmunoprecipitation assay can detect 
myosin dimers, and therefore, our inability to coprecipitate two 
Myo4p heavy chains suggests that Myo4p does not form dimers 
in cell extracts.
Myo4p is a monomer by EDC cross-linking
One limitation of the coimmunoprecipitation assay is that 
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To capture these potential dimers, we added the zero-length 
chemical cross-linker 1-Ethyl-3-[3-dimethylaminopropyl]carbo
diimide hydrochloride (EDC) to yeast lysates, and then deter-
mined by Western blot whether EDC increased the molecular 
weight of Myo4p to a size consistent with a dimer. We performed 
the cross-linking in cell lysates from MYO4-GFP cells because 
GFP increases the molecular weight of the Myo4p heavy chain 
to  15 kD more than Myo2p. Therefore, a cross-linked Myo4p 
dimer should be larger and migrate more slowly than a cross-
linked Myo2p dimer. MYO4-GFP cell lysates were incubated with 
or without 50 mM EDC for 1 h at room temperature. Subsequent 
Western blot analysis revealed that EDC-treated Myo4p-GFP 
migrated as a larger complex compared with untreated Myo4p-
GFP (Fig. 1 D). Reprobing the same blot for Myo2p revealed 
that EDC-treated Myo2p showed a dramatic increase in molec-
ular weight compared with untreated Myo2p (Fig. 1 D). Impor-
tantly, EDC-treated Myo4p-GFP was smaller than EDC-treated 
Myo2p, indicating that the cross-linked Myo4p-GFP complex 
was not Myo4-GFP dimers. Instead, the EDC-treated Myo4-
GFP complex probably refl  ects Myo4p-GFP cross-linked to 
She3p. In support of this conclusion, She3p was detected at 
the same location as EDC-treated Myo4p on Western blots 
(Fig. 1 D). Second, in she3∆ cells, EDC-treated Myo4p-GFP did 
not exhibit a considerable size shift, whereas in the same ex-
tracts EDC-treated Myo2p still migrated as a large complex 
(Fig. 1 D and unpublished data). Thus, cross-linking failed to 
capture Myo4p dimers and indicated that the bulk of Myo4p in 
cell extracts exists as a monomer coupled to She3p.
Hydrodynamic analysis of Myo2p 
and Myo4p
To test further the oligomeric state of Myo4p, we partially 
 purifi  ed native Myo2p and Myo4p from cell extracts and per-
formed velocity sedimentation analysis. Myo2p-1/2TAP and 
Figure 1.  Myo4p is a monomeric, class V myosin in cell extracts. (A) Paircoil predictions for myosin Va, Myo2p, and Myo4p. Myo4p has a predicted 
coiled-coil domain of only 30 amino acids, considerably shorter than predicted coiled-coil domains in myosin Va or Myo2p. (B) Myo4p-HA does not co-
precipitate with Myo4p-GFP. MYO4-HA was expressed on a CEN/ARS plasmid in YPT87. Myo4p-GFP was immunoprecipitated from yeast lysates, and 
supernatants and pellets were subsequently analyzed by Western blot. Myo4p-HA was not detected in the Myo4p-GFP immunoprecipitate, but She3p-HA 
was clearly present. S3 is a high-speed supernatant and represents the starting material for the immunoprecipitations. (C) Myo2p-HA coprecipitates with 
Myo2p-1/2TAP. MYO2-HA and MYO4-HA were expressed on CEN/ARS plasmids in YPT117 and YPT118, respectively. Myo2p-1/2TAP and Myo4p-1/
2TAP were immunoprecipitated from cell lysates with IgG beads, and supernatants and pellets were subsequently analyzed by Western blot. Myo2p-HA 
was evident in immunoprecipitates of Myo2p-Tap1/2, but Myo4p-HA was not detected in Myo4p-Tap1/2 immunoprecipitates. (D) Chemical cross-linking 
indicates that Myo4p is a monomer. Cell lysates from YPT68 and YPT70 were treated with 50 mM EDC for 1 h at RT and then analyzed by Western blot. 
EDC-treated Myo4p-GFP migrated as a larger complex than untreated Myo4p-GFP, but smaller than EDC-treated Myo2p. Note that a single Myo4p-GFP 
polypeptide is  15 kD larger than a single Myo2p polypeptide, so a cross-linked Myo4p-GFP dimer would be expected to be larger than a cross-linked 
Myo2p dimer. She3p-HA cross-links with Myo4p-GFP. EDC-treated Myo4p-GFP in she3∆ extracts showed a minimal shift in size compared with untreated 
Myo4p-GFP.JCB  1196
Myo4p-1/2TAP were adsorbed onto IgG resin from cell lysates 
and then eluted with TEV protease. Both eluates were enriched 
for either Myo2p or Myo4p and showed robust activity in an actin 
fi  lament gliding assay (Fig. 3 A; and Videos 1 and 2, available 
at http://www.jcb.org/cgi/content/full/jcb.200707080/DC1). 
The TEV eluates were analyzed by velocity sedimentation on 
5–20% sucrose gradients. Silver stain and Western blot analysis 
of the sucrose gradient fractions revealed that Myo2p sedi-
mented as a larger complex than Myo4p (Fig. 2 A). Based on 
the sedimentation of four protein standards, we estimate sedi-
mentation values of 9.1 ± 0.6S for Myo2p and 7.6 ± 0.3S for 
Myo4p (Fig. 2 A). Interestingly, the sedimentation value of 
Myo2p is similar to myosin V (10S), which forms a dimer, and the 
sedimentation value of Myo4p is similar to myosin IXb (7.3S), 
a monomeric myosin (Post et al., 2002; Wang et al., 2004).
EM analysis of Myo2p and Myo4p
To confi  rm visually the oligomeric state of Myo2p and Myo4p, 
we imaged both motors by rotary metal shadowing. Images of 
Myo2p contained many examples of a Y-shaped molecule with 
globular domains at each end (Fig. 2 B). Previously published 
images of myosin V dimers revealed a similar structure and 
suggest that two of the globular domains in our images corre-
spond to the motor domains of Myo2p and the third to the C tail 
(Krementsov et al., 2004). The images thus confi  rm that Myo2p 
is a dimer. In contrast, most images of Myo4p revealed a single 
globular domain, occasionally with an extended tail (Fig. 2 B). 
Rarely, we observed two globular domains in proximity, but the 
spacing of the heads was noticeably different than Myo2p. 
The density of images of double-headed motor in several fi  elds 
of Myo2p and Myo4p was 3.8 /μm
2 and 0.4/μm
2, respectively, 
and the density of images of single globular domains of Myo2p 
and Myo4p was 12/μm
2 and 10.8/μm
2, respectively (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200707080/DC1). 
The number of single globular domains may be infl  ated, as dust 
and debris often appear similar to a single globular domain. 
Thus, evidence from coimmunoprecipitation, cross-linking, 
hydrodynamic analysis, and electron microscopy indicated that 
Figure 2.  Hydrodynamic and EM analysis of 
partially puriﬁ  ed  myosins.  (A) TEV-eluted 
Myo4p, Myo2p, Myo2/4p, and Myo4/2p 
were analyzed by velocity sedimentation in 
5–20% sucrose gradients. Fractions were col-
lected from the bottom of the gradient and an-
alyzed by silver stain and Western blot. 
Parallel gradients containing the protein stan-
dards catalase, aldolase, albumin, and oval-
bumin were used to generate a sedimentation 
coefﬁ   cient curve and obtain sedimentation 
coefﬁ   cient values of 9.1 ± 0.6S for Myo2p 
(n = 5), 7.6 ± 0.3S for Myo4p/She3p (n = 8), 
7.4  ± 0.2S for Myo4p she3∆, (n  = 4), 
9.1 ± 0.4S Myo4/2p (n = 2), and 7.3S for 
Myo2/4p. Note that She2p disassociates from 
Myo4p and She3p in the sucrose gradient. 
(B) EM images indicate that Myo2p is a dimer 
and Myo4p is a monomer. Partially puriﬁ  ed 
(TEV eluted) Myo2p-GFP and Myo4p-GFP 
were analyzed by rotary shadowing electron 
microscopy. Representative images of Myo2p-
GFP and Myo4p-GFP are shown. Myo2p-GFP 
images contain many examples of three globu-
lar domains linked into a Y-shaped structure. 
For Myo4p-GFP, the predominant image is of a 
single dot, likely the motor domain. In a few 
examples (left-most images), both the head 
and neck domains are visible. In very rare in-
stances (bottom right), what might be a Myo4p-
GFP dimer is visible.MYO4P IS A MONOMER ADAPTED TO TRANSPORT MRNA • DUNN ET AL. 1197
Myo4p is a monomeric myosin, sharply distinguishing it from 
other class V myosins.
Puriﬁ  cation of active Myo4p and Myo2p
Like other class V myosins, Myo4p moves cargo, in this case 
mRNA, rapidly and continuously within cells. To gain a better 
understanding of how monomeric Myo4p transports ASH1 
mRNA in vivo, we purifi  ed native Myo4p and analyzed its mo-
tility in vitro. We also purifi  ed Myo2p to compare the motility 
of Myo4p to a known dimer. TEV-eluted Myo2p and Myo4p 
fractions were highly enriched for each myosin, but contained 
additional proteins (Fig. 3 A). Most of these were not associated 
with the myosins, as they did not cofractionate in the sucrose 
gradients (Fig. 2). TEV-eluted Myo4p contained both She3p 
and She2p, but only She3p cofractionated with Myo4p on su-
crose gradients, suggesting that She2p had dissociated from 
Myo4p/She3p. The weak interaction between She2p and Myo4p/
She3p indicated that only a fraction of purifi  ed Myo4p/She3p 
was associated with She2p. To avoid analyzing two different 
species of Myo4p, we purifi  ed Myo4p from she2∆ cells.
To further purify Myo4p and Myo2p, we used an actin 
bind and release step. A similar method using microtubules was 
recently used to purify dynein from S. cerevisiae (Reck-Peterson 
et al., 2006). TEV-eluted myosins were incubated with phalloidin-
stabilized F-actin in the absence of ATP to promote binding to 
actin fi  laments. Actin fi  laments and attached myosins were sed-
imented by centrifugation and then incubated with buffer con-
taining ATP to release myosins from actin fi  laments. The actin 
fi  laments were again sedimented by centrifugation, and the su-
pernatant (ATP-release) was saved. Silver stain analysis of the 
ATP-releases revealed that Myo4p and Myo2p were highly en-
riched and pure (Fig. 3 A). Both fractions contained myosin 
Figure 3.  Proﬁ  le and oligomeric state of puriﬁ  ed myosins. 
(A) Silver stains of TEV-eluted fractions and ATP released 
actin-afﬁ  nity puriﬁ  ed (AA pure) fractions of Myo2p, Myo4p, 
Myo2/4p, and Myo4/2p. Note that She3p only copuriﬁ  es 
with myosins containing the C-tail of Myo4p. (B) Puriﬁ  ed 
Myo2p is a dimer, whereas puriﬁ  ed Myo4p is a monomer. 
Actin afﬁ  nity puriﬁ  ed myosins were cross-linked with 40 mM 
EDC and NHS for 1 h at RT. Cross-linked proteins were run 
on the same gel and analyzed by Western blot. Cross-
linked Phosphorylase b was used as a high molecular 
weight marker. The bulk of cross-linked Myo4p migrated 
between 270 and 300 kD, while Myo2p migrated be-
tween 400 and 450 kD. When overexposed (right panel), 
a second, much larger Myo4p band that is likely cross-
linked Myo4p dimers is detected. (C) Puriﬁ  ed Myo4/2p is 
a dimer, whereas puriﬁ  ed Myo2/4p is a monomer. Actin 
afﬁ  nity puriﬁ  ed myosins were cross-linked and analyzed by 
Western blot as in B. The Myo4/2p chimera migrates at the 
same location as Myo2p, while the Myo2/4p chimera mi-
grates at the same size as Myo4p. She3p cross-links with 
Myo4p and the Myo2/4p chimera.JCB  1198
light chains ( 15 kD), and the Myo4p fraction contained She3p. 
In addition, a small amount of actin was present representing 
short fi  laments that had not completely sedimented. Myo2p ap-
peared to be clipped during purifi  cation, as the protein bands 
between 75 and 150 kD that were apparent by silver stain were 
detected with anti-Myo2p-tail antibody by Western blot (un-
published data). Thus, the two-step purifi  cation yielded very 
pure preparations of native Myo4p and Myo2p.
Puriﬁ  ed Myo4p is a monomer
To demonstrate that purifi  ed Myo4p and Myo2p maintain their 
oligomeric status of monomer and dimer, respectively, we incu-
bated both purifi  ed myosins with EDC. EDC-treated and un-
treated samples were run on the same gel and detected by 
Western blot with antibodies against the C-tails of Myo4p and 
Myo2p (Fig. 3 B). EDC-treated Myo2p migrated as a large band 
between 400 and 450 kD, which fi  ts well with the theoretical 
molecular weight of two cross-linked Myo2p heavy chains and 
some of the associated myosin light chains. EDC-treated Myo4p 
migrated between 270 and 325 kD, which approximates a single 
Myo4p heavy chain cross-linked to She3p and the light chains. 
Interestingly, when the fi  lm was overexposed, a second higher 
molecular weight Myo4p band was detected. This band mi-
grated slower than cross-linked Myo2p, suggesting that a small 
amount of Myo4p had formed into dimers. Reprobing the blot 
with anti-She3p antibodies revealed that She3p co-migrated with 
EDC-treated Myo4p (Fig. 3 C). We also tested cross-linkers 
with different reaction groups and longer spacers than EDC, but 
they cross-linked Myo2p less effi  ciently than EDC and none 
generated Myo4p dimers (Fig. S1, available at http://www.jcb
.org/cgi/content/full/jcb.200707080/DC1). We conclude that 
the majority of purifi  ed Myo4p exists in a monomeric state 
bound to She3p, but a small fraction of Myo4p forms dimers 
when concentrated.
Myo4p and Myo2p exhibit different 
motility properties
We analyzed the motility and processivity of purifi  ed Myo2p 
and Myo4p in an actin fi  lament gliding assay. Nonprocessive 
Figure 4.  Motility analysis of puriﬁ  ed myosins. Actin gliding assays were 
performed by directly adsorbing puriﬁ  ed myosins onto the surface of a 
glass coverslip in a motility chamber. Fluorescently labeled actin ﬁ  laments 
were added and movement was recorded within the ﬁ  rst 5 min of adding 
actin ﬁ   laments to the motility chambers, except at low motor densities, 
when ﬁ  lament landing was slower. Motor density was determined by quan-
titative Western blots of the amount of motor input and the amount that 
passed through the chamber without binding. Myosins were diluted before 
addition to the motility chambers. (A) The velocities of Myo2p and Myo4p 
respond differently to changes in motor density. The velocity of actin ﬁ  la-
ments decreases as Myo2p density decreases, indicative of a nonproces-
sive motor. In contrast, the velocity of actin ﬁ  laments increases as Myo4p 
density decreases. (B) The decreased ﬁ  lament velocity at higher Myo4p 
density is not due to She3p. The velocity vs. motor density proﬁ  les  of 
Myo4p with She3p (top panel) and without She3p (bottom panel) are similar. 
(C) The velocity versus motor density proﬁ  le of Myo2/4p resembles Myo4p, 
whereas the proﬁ  le of Myo4/2p is similar to Myo2p. Note that the maxi-
mum velocity of Myo4/2p is comparable to Myo4p and the maximum 
velocity of Myo2/4p is equivalent to Myo2p. Shown are representative 
curves for each myosin, each point is the average ﬁ   lament velocity 
(μm/s ± SD) for all ﬁ  laments analyzed in a chamber.MYO4P IS A MONOMER ADAPTED TO TRANSPORT MRNA • DUNN ET AL. 1199
motors exhibit decreasing fi  lament velocity as motor density 
decreases, whereas processive motors show little change in ve-
locity over several orders of motor density (Rock et al., 2000). 
In addition, processive motors generate fi  lament movement at 
densities of 1–2 motors/μm
2. Purifi  ed Myo2p behaved as a non-
processive motor (Fig. 4 A). At high motor densities, Myo2p 
moved actin fi  laments at velocities of 2–2.5 μm/s, which de-
creased as motor density decreased. Below  50 motors/μm
2, 
actin fi  laments did not land on coverslips. The maximum velocity 
of purifi  ed Myo2p is consistent with the velocity measured for 
secretory vesicles in vivo. Our analysis of the motility of puri-
fi  ed Myo2p confi  rms previous work on Myo2p motility in cell 
lysates (Reck-Peterson et al., 2001).
In contrast, Myo4p produced an actin velocity curve that 
was the inverse of Myo2p (Fig. 4 A). At the highest Myo4p den-
sities, actin fi  laments moved at 0.45–0.65 μm/s, but as Myo4p 
density decreased, fi  lament velocity increased to a maximum of 
1.5–1.75 μm/s. This unique velocity curve is unlikely to result 
from inactive or damaged Myo4p, as only active myosin should 
be purifi  ed with the actin affi  nity step. Further, we detected very 
few nonmotile actin fi  laments on the coverslips, which indicates 
healthy active motors (Videos 1–4). In contrast to our results, an 
earlier study of Myo4p showed that Myo4p generated a velocity 
curve similar to Myo2p in actin gliding assays (Reck-Peterson 
et al., 2001). Two differences in methodology may account for 
this discrepancy. First, Reck-Peterson et al. (2001) studied 
Myo4p-GFP in cell lysates, whereas we used purifi  ed Myo4p. 
Second, in the actin gliding assay, Reck-Peterson et al. tethered 
Myo4-GFP to coverslips with anti-GFP antibodies, whereas we 
directly adsorbed Myo4p to coverslips. Bivalent antibodies have 
the potential to bind two Myo4p-GFP motors and perhaps stabi-
lize Myo4p dimers. Although the velocity curve of Myo4p is 
different from the nonprocessive curve of Myo2p, we suspect 
that Myo4p is also nonprocessive, as below Myo4p densities of 
 100 motors/μm
2, fi  laments did not land on the coverslips.
Because Myo4p co-purifi  es with She3p, we tested whether 
She3p affected the ability of Myo4p to move actin fi  laments. 
We purifi  ed Myo4p-1/2TAP from she3∆ cells and analyzed 
Myo4p motility. We observed the same inverse relation between 
fi  lament velocity and Myo4p density, indicating that She3p was 
not affecting Myo4p activity (Fig. 4 B). The slight difference in 
the lowest density of Myo4p that supports fi  lament gliding be-
tween fi  gures is likely due to variability in the amount of non-
functional motor in different preparations of Myo4p and errors 
in calculating motor density in the fl  ow cells.
Single-molecule analysis of Myo2p-GFP and 
Myo4p-GFP motility
To test more defi  nitively whether Myo2p and Myo4p move 
processively, we analyzed the motility of purifi  ed Myo2p-GFP 
and Myo4p-GFP on actin bound to the coverslip surface by 
total internal refl  ection fl  uorescence (TIRF) microscopy. First, 
we measured the total fl  uorescence intensity and the photo-
bleaching of individual spots to determine how many GFP 
molecules exist in each. The initial intensity of a spot minus 
the background after photobleaching was measured and plotted 
as a histogram (Fig. S3, available at http://www.jcb.org/cgi/
content/full/jcb.200707080/DC1). The data for Myo2p-GFP 
and Myo4p-GFP were each plotted as separate histograms 
and each were fi  tted with a two-peak Gaussian function cor-
responding to a population with a large intensity (25500 a.u.) 
and a smaller intensity (13,000 a.u.), probably representing spots 
with two and one GFP molecules, respectively. This result re-
vealed that most Myo2p-GFP spots contained two GFPs, whereas 
the majority of Myo4p-GFP spots contained a single GFP, 
indicating that Myo2p-GFP is a dimer and Myo4p-GFP is a 
monomer (Fig. S3). In the presence of ATP, most Myo2p-GFP 
spots failed to move along actin fi  laments, and instead either 
released from the fi  laments or bleached. At low (300 nM) ATP, 
a small fraction of Myo2p-GFP ( 2%) moved processively for 
distances less than 0.5 μm, and fl  uorescence imaging with one-
nanometer accuracy (FIONA) analysis revealed a trend toward 
step of 36 and 72 nm (Fig. S4). One interpretation of the results 
is that Myo2p-GFP is an intermediate duty ratio motor with 
a low probability of remaining associated with a fi  lament over 
a few enzymatic cycles, and thus, in a population of Myo2p mo-
tors a small fraction will move processively for short distances. 
This conclusion is supported by previous published work, and 
we suggest that Myo2p is a weakly processive motor (Reck-
Peterson et al., 2001). In contrast, none of the Myo4p-GFP 
spots with fl  uorescent intensity equivalent to one or two GFPs 
moved processively at any ATP concentration. Interestingly, 
we observed several Myo4p-GFP spots with fl  uorescent inten-
sity equivalent to at least 3 GFPs, and of these,  20% moved 
processively (Fig. 5 B), taking a range of step sizes (Fig. S4).
The variability in step size in this case may be related to the 
presence of multiple, simultaneously interacting myosin mol-
ecules with actin, which might dampen the measured step size 
(Leduc et al., 2007). Back steps of Myo4p-GFP were occa-
sionally observed at 100 nM ATP, and back-and-forth move-
ment of Myo4p-GFP was also observed at high (1 mM) ATP. 
The results suggest that Myo4p is nonprocessive as a monomer, 
but at a low frequency assembles into ensembles capable of 
processive movement.
Myo2p-Myo4p chimeras
The strikingly different velocity curve of Myo4p as compared 
with other myosins could be due to unique properties of the 
Myo4p motor domain or in its oligomeric state (i.e., monomer 
versus dimer). To distinguish between these possibilities, we 
constructed chimeras consisting of the motor domain from one 
myosin fused to the IQ and C-tail domains of the other myosin. 
Myo2/4p (Myo2 motor − Myo4 IQ + C-tail) was expressed 
with a C-terminal 1/2TAP tag in myo4∆ cells and purifi  ed as 
described for Myo4p-1/2TAP. The Myo4/2p chimera (Myo4 
motor − Myo2 IQ + C-tail) was expressed with a C-terminal 
1/2TAP tag in MYO2-GFP cells and purifi  ed as described for 
Myo2p-1/2TAP with one additional step. Because Myo4/2p 
contains the coiled-coil domain of Myo2p, a small amount of 
Myo4/2p-1/2TAP may dimerize with Myo2p-GFP. To eliminate 
these mixed dimers from purifi  ed Myo4/2p, we incubated the 
TEV eluate with beads coated with anti-GFP antibodies. 
The unbound fraction was then subjected to the actin affi  nity step 
to further purify Myo4/2p.JCB  1200
The structure and protein composition of the purifi  ed chi-
meras resembled the myosin from which they obtained their 
C-tail. The protein profi  le of purifi  ed Myo2/4p contained She3p 
and myosin light chains (Fig. 3 A). EDC cross-linking of purifi  ed 
Myo2/4p increased its molecular weight similarly to purifi  ed 
Myo4p, and She3p was evident in the cross-linked complex 
(Fig. 3 C). Myo2/4p had a velocity sedimentation coeffi  cient of 
7.3S, similar to Myo4p (Fig. 2). These results indicated that the 
Myo2/4p chimera, like Myo4p, is a monomer that binds directly 
to She3p, confi  rming previous results that She3p interacts with 
the C-tail of Myo4p (Bohl et al., 2000). In contrast, the Myo4/2p 
chimera did not co-purify She3p, and EDC-treated Myo4/2p 
migrated at a similar molecular weight as EDC-treated Myo2p 
(Fig. 3, A and C). In addition, velocity sedimentation analysis of 
purifi  ed Myo4/2p revealed a sedimentation coeffi  cient of 9.1S, 
identical to Myo2p (Fig. 2). Thus, the Myo4/2p chimera, like 
Myo2p, is a dimer.
To determine whether the motor domain or oligomeric 
state of Myo4p limits its ability to move actin fi  laments at high 
density, we analyzed Myo4/2p and Myo2/4p in the actin fi  lament 
gliding assay. Myo4/2p behaved similarly to Myo2p: as the 
density of Myo4/2p decreased, the velocity of actin fi  laments 
decreased (Fig. 4 C). This profi  le suggests that Myo4/2p, like 
Myo4p, is a nonprocessive motor. Interestingly, Krementsova 
et al. (2006) engineered a myosin chimera that contained the 
Myo4p motor and myosin V C-tail. In contrast to Myo4/2p, 
their myosin chimera was processive. In addition, they found 
that their chimera exhibited longer run lengths in lower ionic 
strength buffers. To determine whether Myo4/2p was proces-
sive at lower salt concentrations, we tested the motility of 
Myo4/2p in the actin fi  lament gliding assay in buffer containing 
25 mM KCl. There was no difference in the velocity curve at 
25 mM KCl compared with higher salt buffers, indicating that 
the difference between the chimeras is not due to buffer condi-
tions (unpublished data). Instead, the results suggest that subtle 
differences in the coiled-coil domains of Myo2p and myosin V 
may be crucial for generating processivity. Similar to Myo4p, 
Myo2/4p showed an inverse relationship between motor density 
and velocity: as Myo2/4p density decreased, actin fi  lament ve-
locity increased (Fig. 4 C). Importantly, the maximum velocity 
Figure 5.  Myo2p is weakly processive and Myo4p 
ensembles move processively. Stepping traces and 
photobleaching of Myo2p-GFP and Myo4p-GFP as 
measure by FIONA. (A) Myo2p-GFP. (a–c) Stepping 
traces of representative Myo2p-GFP spots measure by 
FIONA and (d – f) respective photobleaching of the 
spots. Only 2% of spots show processive movement 
illustrated in (f). (B) Myo4p-GFP. (a–c) Stepping traces 
of representative Myo4p-GFP spots measure by FIONA 
and (d–f) respective photobleaching of the spots. 
Monomers (a, d) and potential dimers (b and e) of 
Myo4p-GFP do not move processively, but ensem-
bles (c and f) of at least three Myo4p-GFPs move 
processively. Note that Myo2p-GFP and Myo4p-GFP 
were imaged with different cameras resulting in differ-
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of Myo2/4p was similar to Myo2p, and Myo4/2p velocity was 
similar to Myo4p, suggesting that the basic enzymatic proper-
ties of the motors had not substantially changed in the chimeras. 
Thus, the results indicate that the slowing of actin fi  laments at 
higher Myo4p density is not due to the properties of the Myo4p 
motor domain. Rather, they suggest that the monomeric status 
of Myo4p allows it to move fi  laments more effi  ciently than 
Myo2p at low motor densities.
The motor domains of Myo2p and Myo4p 
are functionally interchangeable
We next examined whether the myosin chimeras could func-
tionally replace the wild-type myosins. To determine whether 
Myo2/4p localizes Ash1p to the daughter cell nucleus, we used 
a growth assay that is sensitive to the localization of Ash1p. 
pHO-ADE2 cells grow in the absence of adenine, because 
Ash1p localizes exclusively to the daughter cell, and its absence 
from the mother cell allows for expression of ADE2 and syn-
thesis of adenine. pHO-ADE2, myo4∆ cells fail to grow without 
adenine because Ash1p accumulates in the nuclei of both mother 
and daughter cells where it represses expression of ADE2. 
We expressed from low copy plasmids either MYO4 or MYO2/4 
in pHO-ADE2, myo4∆ cells. Compared with cells containing 
only an empty vector, both MYO4 and MYO2/4 restored growth in 
the absence of adenine, suggesting that Myo2/4p was suffi  cient 
to localize Ash1p to the daughter cell (Fig. 6 A). To confi  rm that 
Myo2/4p localizes ASH1 mRNA to the bud tip, we examined 
the same cells by FISH with probes against ASH1 mRNA. 
The results showed that ASH1 mRNA localized to the bud tip in 
66% of cells expressing MYO4 and 62% of cells expressing 
MYO2/4 (Fig. 6 B). In contrast, none of the cells containing 
only an empty vector showed localized ASH1 mRNA. Thus, 
Myo2/4p can functionally substitute for Myo4p to transport 
ASH1 mRNA to the bud tip.
To determine whether Myo4/2p could substitute for Myo2p, 
we expressed either MYO2 or MYO4/2 on low copy plasmids in 
myo2-66 cells, which contain a temperature-sensitive mutation 
in the MYO2 motor domain, rendering the motor inactive at ele-
vated temperature (Johnston et al., 1991). Because MYO2 is es-
sential, myo2-66 cells do not grow at elevated temperatures. 
All strains, myo2-66, myo2-66 + MYO2, and myo2-66 + MYO4/2 
grew well at 25°C, but only MYO2 and MYO4/2 grew robustly 
at 30°C (Fig. 6 C). Although MYO4/2 rescued growth at 30°C, 
it grew poorly at 37°C compared with MYO2. To determine 
whether Myo4/2p mediated vesicle transport to the bud at re-
strictive temperatures, we examined the distribution of Sec4p, 
which accumulates on secretory vesicles (Goud et al., 1988). 
All strains, myo2-66, myo2-66 + MYO2, and myo2-66 + MYO4/2, 
localized GFP-Sec4p to buds at 25°C (unpublished data). 
But only Myo2p and Myo4/2p restored localization of GPF-Sec4p 
to buds of myo2-66 cells at 30°C (Fig. 6 D). At 37°C, GFP-
Sec4p was detected in buds of cells expressing Myo4/2p, but 
GFP-Sec4p localization was stronger in cells expressing Myo2p. 
The velocity of Myo4/2p was about half of Myo2p (Fig. 4, 
A and C), which may explain the weaker localization of GFP-
Sec4p in MYO4/2 cells. The results demonstrate that Myo4/2p 
mediates vesicle transport, though less effi  ciently than Myo2p.
Discussion
Although a large body of information exists on the mechanism 
of molecular motor movement, limited work has been done 
to address how the activity of a motor translates to success-
ful cargo transport in vivo (Forkey et al., 2003). In particular, 
the physical and biochemical differences between membrane-
bound vesicles and mRNAs would seem to require different 
properties in a motor protein. We have analyzed two closely 
related class V myosins, Myo2p and Myo4p, which transport 
secretory vesicles and mRNA, respectively, in S. cerevisiae. 
We fi nd two important differences between Myo2p and Myo4p. 
First, unlike Myo2p and other known class V myosins, Myo4p 
is a monomer (Reck-Peterson et al., 2000). Second, Myo2p and 
Myo4p differ in their movement along actin fi  laments. Myo2p 
behaves as a nonprocessive motor in actin gliding assays and 
as a weakly processive motor in single-molecule assays. 
In this regard, it is worth noting that myosin V from Drosophila 
melanogaster was also shown to be a low duty ratio motor that 
probably does not move processively (Toth et al., 2005). 
The motility of Myo4p is unique. In an actin gliding assay, the 
velocity of Myo4p increases as motor density decreases. Further, 
single-molecule analysis suggests that although individual 
Myo4p motors are nonprocessive, ensembles of Myo4p move 
processively. Finally, the motor domain of Myo2p can substi-
tute for Myo4p motor to localize ASH1 mRNA, indicating that 
the unique motility of Myo4p is not due to differences in its 
motor domain.
How do the properties of Myo2p and Myo4p allow them 
to transport vesicles and mRNA, respectively, in vivo? Myo2p 
is at best a weakly processive motor, and the run lengths of the 
few processive Myo2p motors were at most  0.5 μm, far 
shorter than the length of a yeast cell. Thus, a single Myo2p is 
unlikely to maintain transport of cargo to the bud tip. The key, 
therefore, to generating sustained movement of cargo is likely 
the presence of multiple Myo2p motors on a vesicle or organ-
elle, increasing the probability that the vesicle or organelle re-
mains associated with a fi  lament during transport to the bud. 
That Myo2p is weakly processive suggests that as few as two or 
three motors may be suffi  cient to sustain transport to the bud, 
and even the smallest vesicle should provide ample surface area 
to bind multiple motors. Although the number of molecules of 
Myo2p on a vesicle or vacuole has not been quantifi  ed, the ex-
pression levels of Myo2p ( 4,000/cell) and Vac8p ( 5,000/
cell), which links Myo2p to vacuoles, offer suffi  cient amounts 
of both proteins to bind multiple Myo2p motors to every vacuole 
(Ghaemmaghami et al., 2003). An important question is whether 
motors bound to the same cargo and fi  lament coordinate their 
enzymatic cycles to ensure sustained and rapid transport in 
vivo. We found that at high densities of Myo2p, when multiple 
motors are attached to a fi  lament, fi  lament velocity is compa-
rable to the rate of vesicle transport in vivo, suggesting that 
Myo2p motors can coordinate their activities in vitro to gener-
ate rapid transport.
How Myo4p generates sustained movement of RNA in vivo 
is likely more complicated. Myo4p is clearly nonprocessive 
as a single-headed molecule, implying that multiple motors are JCB  1202
needed to sustain transport of RNA in vivo. The small size of 
an active zipcode, however, seems to preclude the attachment 
of multiple motors. Our results suggest a potential solution. 
Ensembles of three or more Myo4p motors move processively, 
so instead of Myo4p motors binding to multiple sites along an 
mRNA, like Myo2p on a vesicle, Myo4p may assemble into 
a multimotor complex that can be linked to a single zipcode 
within an mRNA. How Myo4p assembles into ensembles is un-
clear, as there is no evidence that other class V myosins form 
multimotor complexes. The primary structural difference be-
tween Myo4p and other class V myosins is that Myo4p is a 
monomer, suggesting the possibility that as a monomer Myo4p 
is capable of assembling into larger order complexes. She3p 
may be an important component, as it binds tightly and directly 
to Myo4p. She3p binds the C-tail of Myo4p, including the coiled-
coil region (Bohl et al., 2000). She3p also contains an exten-
sive stretch of sequence with a strong probability of forming 
a coiled-coil. Intriguingly, the multicoil program predicts six 
heptad repeats to form a three-stranded coiled-coil. One expla-
nation, then, why Myo4p is a monomer is that the C-tail evolved 
to form association with She3p rather than with itself. Finally, 
She2p, which links Myo4p/She3p to ASH1 mRNA, is a dimer 
and could potentially bind two copies of Myo4/She3p to facili-
tate assembly of Myo4p ensembles.
Another unusual aspect of Myo4p motility is that the ve-
locity of actin fi  laments was threefold higher at low density of 
motors compared with high density. Interestingly, the in vitro 
velocity of Myo4p at high density is similar to the in vivo velocity 
of RNA particles (Bertrand et al., 1998). What generates this 
unique motility of Myo4p is unclear. A chimera of the Myo2p 
motor and C-tail of Myo4p exhibited a similar motility to Myo4p, 
suggesting that either the C-tail of Myo4p regulates the activity 
of the motor or that the monomeric state of the motor protein 
affects its activity. Recent work on myosin Va has shown that 
Figure 6.  The motor domains of Myo2p and Myo4p are interchangeable. (A) Myo2/4p localizes Ash1p to the daughter cell. Four tenfold serial dilutions 
of YPT148, YPT149, and YPT150 at OD600  0.3 were made and spotted onto either SC −leu + adenine or SC −leu −adenine. Plates were incubated 
for 2 d at 30°C. (B) Myo2/4p localizes ASH1 mRNA to the bud tip. FISH analysis of YPT148, YPT149, YPT150 with probes against ASH1 mRNA shows 
that both Myo4p and Myo2/4p localized ASH1 mRNA to the bud tip. Bar = 5 μm. (C) Myo4/2p partially rescues growth of myo2-66 cells. YPT168, 
YPT171, and YPT172 were incubated on Sc −leu at 25, 30, or 37°C. Myo4/2p fully restored growth at 30°C but not at 37°C. (D) Myo4/2p localizes 
GFP-Sec4p at the restrictive temperature. YPT173, YPT174, and YPT175 were incubated in SC −leu for 5 h at 25, 30, or 37°C. Cells were spotted onto 
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the C-tail folds over to bind the motor domain and repress its 
activity, but our results question whether such a mechanism 
explains the behavior of Myo4p (Krementsov et al., 2004; Wang 
et al., 2004). First, velocity sedimentation analysis of myosin 
Va reveals a 14S version, representing the C-tail bound to the 
motor, and an 11S species, which is myosin Va extended. 
Our analysis of Myo4p and Myo2p did not reveal more com-
pact versions of either myosin, suggesting that both are fully 
extended. Second, the slowing of Myo4p velocity is concentra-
tion dependent, whereas the velocity of myosin Va is not affected 
by concentration but instead regulated by Ca
2+ (Krementsov et al., 
2004). Although our results do not rule out a role for the C-tail 
in regulating the activity of the Myo4p motor, we suggest that 
the monomeric state of Myo4p is the likely reason for its un-
usual motility.
To determine the molecular mechanisms of active trans-
port complexes, future work will need to be directed at reconsti-
tuting and analyzing active myosin–cargo complexes. Toward 
this aim, we have developed methods to purify native and active 
Myo2p and Myo4p. RNA transport is especially ripe for recon-
stitution, as the components that link Myo4p to RNA have been 
identifi  ed, and the cargo can be readily synthesized and modi-
fi  ed in vitro. Thus, we can address questions about the minimal 
number of Myo4p motors needed to generate sustained trans-
port and whether multiple zipcodes increase the robustness of 
RNA transport. Similarly, it is now possible to attempt to recon-
stitute vesicle or vacuole transport in vitro. In addition to the 
number of Myo2p motors needed for cargo movement, an im-
portant question is whether an even distribution or clustering of 
Myo2p on the surface of a vesicle facilitates sustained transport. 
Finally, the use of myosin chimeras will enable us to dissect 
further those features of Myo2p and Myo4p that are unique for 
vesicle and RNA transport, respectively, and will lead to a 
broader understanding of how motor proteins have evolved to 
transport different types of cargo.
Materials and methods
Strains and plasmids
All strains used in this study are listed in Table I. MYO4-GFP, MYO4-TAP, 
MYO4-1/2TAP, MYO2-GFP, MYO2-TAP, and MYO2-1/2TAP were made 
by PCR-mediated gene modiﬁ  cation. MYO4-HA and SHE3-HA were made 
by gene replacement of endogenous MYO4 and SHE3, respectively. 
The Myo4-HA plasmid was made by inserting a single HA sequence into an 
engineered BamHI site just upstream of the stop codon. The She3-HA plas-
mid was made by inserting a single HA sequence in an engineered NheI 
site just upstream of the stop codon. Both Myo4-HA and She3-HA were 
subcloned into CEN ARS vectors to allow for expression from a low copy 
plasmid. pHO-ADE-HO 3′ UTR has been described elsewhere (Irie et al., 
2002), and pHO-ADE-HO 3′ UTR myo4∆ was made by PCR-mediated 
gene disruption. To make the Myo2/4 plasmid, PCR products of MYO2 5′ 
UTR and promoter (-579 to +3), MYO4 motor domain (+4 to +2334), 
MYO2 IQ + C-tail (+2347 to +4722), and MYO2 3′ UTR (stop codon + 
370 nucleotides of downstream sequence) were ligated using unique re-
striction sites and inserted into pRS315. To make the Myo4/2 plasmid, 
PCR products of MYO4 5′ UTR and promoter (−687 to +3), MYO2 motor 
domain (+4 to +2346), MYO4 IQ + C-tail (+2335 to +4413), and 
MYO4 3′ UTR (stop codon + 193 nucleotides of downstream sequence) 
were ligated using unique restriction sites and inserted into pRS315. 1/2 
TAP versions of both proteins were made by inserting a PCR product con-
taining the sequence encoding a TEV protease site and IgG-binding do-
main into unique restriction sites just upstream of the stop codon in MYO2/4 
and MYO4/2.
Reagents and antibodies
9E10 (anti-myc) and HA.11 (anti-HA) were purchased from Covance Re-
search Products. JL8 (anti-GFP) was purchased from CLONTECH Labora-
tories, Inc. Antisera against She2p, She3p, Myo4p, GFP, and HA were 
prepared by Cocalico Biologicals. Antibodies were afﬁ  nity puriﬁ  ed using 
either puriﬁ  ed 6× His She2p, 6× His She3p 197–425, or GST-Myo4p 
C-tail (1075 to end). GFP antibodies were afﬁ  nity puriﬁ  ed on a membrane 
containing GFP. HA antibodies were afﬁ  nity puriﬁ  ed on a column contain-
ing HA peptide. ECL reagents, protein molecular weight standards, IgG 
Sepharose 6 Fast Flow, and protein G Sepharose 4 Fast Flow were pur-
chased from GE Healthcare. 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimi
de hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were purchased 
from Pierce Chemical Co. Cross-linked Phosphorylase b, glucose oxidase, 
catalase, phalloidin, and TRITC-phalloidin were purchased from Sigma-
Aldrich. AcTEV protease was purchased from Invitrogen. Actin was pur-
chased from Cytoskeleton, Inc. Anti-Myo2p tail antibody was a gift from 
Mark Mooseker (Yale University, New Haven, CT).
Coimmunoprecipitation
Yeast cultures were grown in YPD or selective media to mid-log phase. 
Cells were harvested by centrifugation, pellets were washed twice with 
cool H2O, and resuspended in 3× cell pellet volume of lysis buffer A 
(20 mM Imidazol, pH 7.2, 150 mM KCl, 2.5 mM MgCl2, 1 mM EGTA, 1 mM 
EDTA, 2 μg/ml of aprotinin, leupeptin, and pepstatin, 400 μM AEBSF, 
5 mM ATP, and 2 mM DTT). Lysates were made by bead-beating 4× 45 s, 
with 60 s in ice water between cycles. The lysate was centrifuged for 5 min 
at 2,000 rcf, and supernatant was collected and centrifuged for 20 min at 
85,000 rpm in a TLA120.2 rotor. The high speed supernatant (S3) was 
used for coimmunoprecipitation experiments. S3 was incubated at 4°C for 
1 h with either free antibody or antibody coupled to beads. Free antibody 
was subsequently linked to protein G beads for 1 h at 4°C. Beads were 
isolated by centrifugation, washed 4× with 50× bead volume of wash 
buffer (150 mM KOAc, 25 mM Hepes-KOH, pH 7.5, 2 mM MgOAc, and 
0.1% IGEPAL), resuspended in 1× SDS-PAGE sample buffer, and boiled. 
Supernatants were mixed with 5× SDS-PAGE sample buffer and boiled.
EDC/NHS cross-linking
EDC and NHS were dissolved in H2O just before use at a concentration of 
1 M. For crude S3 lysates, only EDC was added to a ﬁ  nal concentration of 
50 mM. For TEV and ATP-released actin afﬁ  nity-puriﬁ  ed myosin, both EDC 
and NHS were added to a ﬁ  nal concentration of 40 mM. Samples were 
incubated for 1 h at room temperature and reactions were quenched by 
Table I. Strains used in this study
Strain Genotype
W303 MATa ura3 trp1 leu2 his3 ade2 GAL
YPT3 myo4∆
YPT68 MYO4-GFP
YPT70 MYO4-GFP she3∆
YPT87 MYO4-GFP SHE3-HA
YPT117 MYO2-1/2TAP
YPT118 MYO4-1/2TAP
YPT119 MYO4-1/2TAP she3∆
YPT120 MYO4-1/2TAP she2∆
YPT138 myo4∆ pHO-ADE2-HO 3′ UTR
YPT140 MATa ura3 leu2 his6 ade1 myo2-66
YPT148 myo4∆ pHO-ADE2-HO 3′ UTR + pRS315
YPT149 myo4∆ pHO-ADE2-HO 3′ UTR + MYO4 (LEU2)
YPT150 myo4∆ pHO-ADE2-HO 3′ UTR + MYO2/4 (LEU2)
YPT168 MATa ura3 leu2 his6 ade1 myo2-66 + pRS315
YPT171 MATa ura3 leu2 his6 ade1 myo2-66 + MYO4/2-HA (LEU2)
YPT172 MATa ura3 leu2 his6 ade1 myo2-66 + MYO2-HA (LEU2)
YPT173 MATa ura3 leu2 his6 ade1 myo2-66 GFP-SEC4 + pRS315
YPT174 MATa ura3 leu2 his6 ade1 myo2-66 GFP-SEC4 + MYO4/2-HA 
(LEU2)
YPT175 MATa ura3 leu2 his6 ade1 myo2-66 GFP-SEC4 + MYO2-HA 
(LEU2)JCB  1204
addition of 5× sample buffer. The samples were boiled and run on either 
3.5 or 5% denaturing gels and then analyzed by Western blot. Bio-Rad all-
blue precision plus and Sigma-Aldrich cross-linked Phosporylase b were 
used as size standards. We detected Phosphorylase b by staining Western 
blot membranes with ponceau S before blocking.
Myosin puriﬁ  cation
A modiﬁ  ed TAP tag (1/2TAP) lacking the calmodulin binding domain was 
used for myosin puriﬁ  cation. The tag was added to the C terminus of all 
myosins. 1/2TAP-tagged Myo2p and Myo4p were integrated, whereas 
1/2TAP-tagged MYO2/4 and MYO4/2 were expressed from low copy 
plasmids. Cultures were grown to mid-log phase in YPD and harvested by 
centrifugation. Cell pellets were washed twice with cool H2O, resuspended 
in 1/5 pellet vol lysis buffer A, frozen in liquid N2, and stored at −80°C. 
Frozen cells were lysed by blending in a Waring blender with liquid nitrogen. 
Lysed cells were thawed in 1.5× cell pellet vol of ice-cold lysis buffer A 
  containing 0.3 mg/ml RNase A on a hot plate set to low with constant 
stirring. Thawed lysates were centrifuged for 10 min at 20 g, supernatants 
were collected, and centrifuged for 1 h at 50,000 rpm in a Ti70 rotor. 
Cleared lysate was passed over IgG sepharose columns at 4°C. Columns 
were washed with 250× column vol of lysis buffer without protease inhibi-
tors or ATP. Washed beads were resuspended in 1× column vol lysis buffer 
without protease inhibitors or ATP containing 50–100 U TEV protease and 
incubated overnight at 4°C. Columns were eluted and washed with lysis 
buffer A without protease inhibitors or ATP. Elution fractions were used in 
the assays described or further puriﬁ  ed. TEV eluted myosin was further puri-
ﬁ  ed by incubating with phalloidin-stabilized actin ﬁ  laments (ﬁ  nal actin con-
centration 0.5 μM) for 10–15 min at 4°C. The myosin bound to actin was 
added onto two-step sucrose gradients (100 μl 60% and 300 μl 10% 
sucrose) and centrifuged for 45 min at 45,000 rpm in a SW 50.1 rotor. 
The top of the gradient was discarded, leaving the bottom 250 μl containing 
the myosin bound to actin. ATP was added to the myosin and actin (ﬁ  nal 
ATP concentration 10 mM) and then immediately centrifuged for 25 min at 
85,000 rpm in a TLA 120.2 rotor. The supernatant containing myosin re-
leased from actin was collected and used for motility assays and EDC 
cross-linking.
Sucrose gradients
TEV-eluted myosin was added to the top of 5–20% 5-ml sucrose gradients. 
Sucrose was dissolved in buffer A. Gradients were spun for 16–20 h at 
40,000 rpm in a SW50.1 rotor. Fractions were collected from the bottom 
of the gradients with a peristaltic pump. Parallel gradients containing oval-
bumin, albumin, aldolase, and catalase protein standards were used to 
calculate S values for each myosin.
Rotary shadowing EM
Myo2p-GFP and Myo4p-GFP were diluted to 0.1 mg/ml in 0.5 M ammo-
nium acetate and mixed thoroughly with glycerol. The samples were 
sprayed onto a mica chip and loaded into the vacuum chamber of RFD-
9010 CR Freeze Etching Equipment (RMC Products). Platinum was depos-
ited by rotary shadowing at an angle of 9° with 3 KV and 70 mA. Carbon 
was deposited to reinforce the replica at an angle of 90° with 2.5 KV and 
90 mA. The replicas were prepared by ﬂ  oating on clean water and lifted 
onto formvar-carbon coated cupper grids and observed in an electron 
microscope (JEM-1200EX II; JEOL).
Actin gliding assays
Actin gliding assays were preformed as described in Rock et al. (2000) 
with the following changes. Grease-coated coverslips were used as spac-
ers to make the motility chambers. Buffer A without protease inhibitors or 
ATP was used for all washes. Coverslips were not coated with nitrocellu-
lose. Chambers were pre-blocked with 0.01 mg/ml BSA in buffer A, 
washed, and puriﬁ  ed myosin was added. The myosin was incubated in 
the chamber for 30+ min on wet ice. Motility buffer (10 mM imidazole, 
pH 7.2, 75 mM KCl, 1 mM EGTA, 2.5 mM MgCl2, 10 mM Mg-ATP, 8 mM 
DTT, 0.2 mg/ml glucose oxidase, and 0.1 mg/ml catalase) was mixed 
with TRITC-phalloidin–stabilized actin ﬁ  laments (8 nM ﬁ  nal) and dextrose 
(0.25% ﬁ  nal). Unlabeled actin was not used to block dead myosin. Actin 
ﬁ  laments were observed on a ﬂ  uorescence microscope (TE2000; Nikon) 
equipped with a 100×/NA 1.4 lens (Nikon), and images were acquired 
with an ORCA-ER CCD camera (Hamamatsu) using IPLab software (Scan-
alytics, Inc.). Videos were taken within the ﬁ   rst 5 min of adding actin 
in motility buffer, except at low motor densities when actin landing 
was slower. Filaments were tracked manually from frame to frame to com-
pute velocity.
Single-molecule motility assay
Single-molecule motility assay and FIONA analysis using TIRF microscopy 
was performed and quantiﬁ  ed as described previously (Yildiz et al., 2003; 
Snyder et al., 2004; Sakamoto et al., 2005). Fluorescence intensities of in-
dividual spots were measured as follows. Myosin solutions without ATP in 
single-motility buffer were added into a ﬂ  ow-chamber that had actin ﬁ  la-
ments bound to the surface, and were incubated for 2 min at room temper-
ature. The actin ﬁ  laments were a copolymer with 10% biotin-labeled actin + 
90% unlabeled actin (Sakamoto et al., 2000). They were bound to the 
coverslip surface via a biotin-avidin sandwich. The free myosin was 
washed out with 600 μl single-molecule buffer (SMB: 20 mM MOPS, 
pH 7.2, 5 mM MgCl2, 0.1 M EGTA, and 50 mM KCl) containing 1 mg/ml 
bovine serum albumin, 50 mM DTT, and an oxygen scavenging system 
(125 mg/ml glucose, 1,665 units glucose oxidase (G-7076; Sigma-Aldrich), 
and 26,000 units Catalase (106810; Roche). The ﬂ  ow-chamber was then 
placed on a microscope (IX70; Olympus) and observed through a 60×/
NA 1.45 lens (Olympus) in TIRF mode at 25°C. Two relay lenses of 1.5 
and 2.5× were also used to achieve a total magniﬁ  cation of 225. Images 
were captured with either a Micromax CCD (Roper Scientiﬁ  c) or an Andor 
EMCCD DV 897 using Andor iQ software. The surface of the ﬂ  ow cham-
bers was ﬁ  rst checked to determine whether myosin molecules were bound 
to actin ﬁ   laments. A manual shutter to block the light was closed and 
the stage was moved to a different ﬁ  eld. To prevent drifting of stage, the 
shutter was closed 2–4 min. Image acquisition started when the shutter 
was reopened.
Data analysis of intensity and photobleaching of individual spots
To analyze spot intensity and photobleaching, an 8 × 8 pixel region of 
interest (ROI) was applied to each spot and the integrated intensities for 
all frames were determined with MetaMorph (Molecular Devices). Back-
ground signal intensities were subtracted from the measured intensities fol-
lowing photobleaching of each 8 × 8 pixel ROI.
FISH
YPT148, YPT149, and YPT150 were grown overnight in minimal media lack-
ing leucine. The overnight cultures were diluted into fresh minimal media 
lacking leucine and incubated at 30°C until achieving OD600  0.5. Cells 
were ﬁ  xed in 4% formaldehyde for 45 min at room temperature, washed, 
and then spheroplasted. Spheroplasts were adsorbed onto poly-L-lysine 
coated glass coverslips and incubated in hybridization mix (50% formamide, 
5× SSC 1 mg/ml, yeast tRNA,100 μg/ml Heparin, 1× Denhardt's Solu-
tion, 0.1% Tween 20, 0.1% Triton X-100, and 5 mM EDTA, pH 8.0) for 
1 h at room temperature. Samples were incubated in hybridization mix 
containing an anti-sense, Dig-labeled RNA probe against ASH1 mRNA 
overnight at 37°C. Samples were washed in 0.2× SSC and then incu-
bated with mouse anti-Dig in 0.05 M Tris-Cl, pH 7.5, 0.15 M NaCl, and 
5% fetal bovine serum for 30 min at 37°C. Samples were washed in 0.05 M 
Tris-Cl, pH 7.5, 0.15 M NaCl, and 0.05% Tween 20 and then incubated 
with goat anti–mouse Alexa488 in 0.05 M Tris-Cl, pH 7.5, 0.15 M NaCl, 
and 5% fetal bovine serum for 1 h at room temperature. Samples were 
then washed in 0.05 M Tris-Cl, pH 7.5, 0.15 M NaCl, and 0.05% Tween 20 
and then mounted on glass slides. Samples were observed at room 
temperature on a ﬂ   uorescence microscope (TE2000; Nikon) equipped 
with a 100×/NA1.4 lens (Nikon), and images were acquired with an 
ORCA-ER CCD camera (Hamamatsu) using IPLab software (Scanalytics, 
Inc.). Cropping and brightness/contrast adjustments were made in Adobe 
Photoshop.
Growth assays
For Ash1p localization, YPT148, YPT149, and YPT150 were grown over-
night in synthetic media lacking leucine (SC −leu) The cultures were ad-
justed to OD600  0.3 and then four tenfold serial dilutions were made from 
the culture. 5 μl of the starting culture and each dilution were spotted onto 
SC −leu plates with or without 25 mg/l adenine. The plates were incu-
bated at 30°C for 3 d. For rescue of myo2-66 growth, YPT168, YPT171, 
and YPT172 were grown overnight in SC −leu. The cultures were diluted 
to OD600  0.3 and four tenfold serial dilutions were made from the culture. 
5 μl of the starting culture and each dilution were spotted onto SC −leu 
plates and incubated for 2 d at either 25, 30, or 37°C.
GFP-Sec4p localization
YPT173, YPT174, and YPT175 were grown overnight in SC −leu. Cultures 
were diluted into fresh SC −leu and incubated for 6 h at 25, 30, or 37°C. 
Cells were ﬁ   xed in 4% formaldehyde, washed, and mounted on glass 
slides. Samples were observed at room temperature on a ﬂ  uorescence MYO4P IS A MONOMER ADAPTED TO TRANSPORT MRNA • DUNN ET AL. 1205
microscope (Nikon TE2000) equipped with a 63×/NA1.4 lens (Nikon), 
and images were acquired with an ORCA-ER CCD camera (Hamamatsu) 
using IPLab software (Scanalytics, Inc.). Cropping and brightness/contrast 
adjustments were made in Adobe Photoshop.
Online supplemental material
Videos 1–4 are representative actin gliding assay movies. Videos 1 and 3 
are TEV-eluted and ATP-released actin afﬁ  nity-puriﬁ  ed Myo2p, respectively. 
Videos 2 and 4 are TEV-eluted and ATP-released actin afﬁ  nity-puriﬁ  ed 
Myo4p, respectively. Collection and display rates are both 2.5 frames/s. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200707080/DC1.
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